*This is the Global version of our site. For specific country information, please choose from the dropdown.
Who we are
Novavax is a global biotechnology company focusing on driving value via our proven recombinant nanoparticle and Matrix-M™ technology through partnerships and R&D. To do this, we are focused on four value drivers: executing on current partnerships, developing our late-stage assets, driving additional partnerships and deals through our technology, and building a robust early-stage pipeline.
Our leadership
Our team has unparalleled experience developing vaccines, conducting early proof-of-concept and clinical development work, and executing successful partnerships for further development and commercialization. Their immense depth of experience is ideally suited to exponentially increase the public health impact of our recombinant protein-based nanoparticle and Matrix-M™ adjuvant technology, while driving value for the Company.
John C. Jacobs
President and Chief Executive Officer
John J. Trizzino
President,
Chief Operating Officer
Chief Operating Officer
Mark Casey
Executive Vice President,
Chief Legal Officer
Chief Legal Officer
Rick Crowley
Executive Vice President,
Chief Operations Officer
Chief Operations Officer
Ruxandra Draghia-Akli, MD, PhD
Executive Vice President,
Head of Research & Development
Head of Research & Development
Jim Kelly
Executive Vice President,
Chief Financial Officer and Treasurer
Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President,
Chief Strategy Officer
Chief Strategy Officer
Silvia Taylor
Executive Vice President,
Chief Corporate Affairs and Advocacy Officer
Chief Corporate Affairs and Advocacy Officer
Ian Watkins
Executive Vice President,
Chief Human Resources Officer
Chief Human Resources Officer
Troy Morgan, JD
Senior Vice President,
Deputy General Counsel & Chief Compliance Officer
Deputy General Counsel & Chief Compliance Officer
Robert Walker, MD
Senior Vice President,
Chief Medical Officer (Interim Head of R&D)
Chief Medical Officer (Interim Head of R&D)
Board of Directors
John C. Jacobs
President and Chief Executive Officer
James F. Young, PhD
Chairman of the Board of Directors
Gregg Alton
Director
Richard Douglas, PhD
Director
Rachel King
Director
Margaret G. McGlynn, R.Ph.
Director
David Mott
Director
Rick Rodgers, MBA
Director